Gleisner N, Meda F, Johnsson M, Rosenstein I, et al. Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barre syndrome: a possible prognostic biomarker for disability at 12 months. J Neurol 2026;273:253.
PMID: 41945172